Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Endocrine Therapy Plus Ovarian Function Suppression and Chemotherapy Based on 21-gene RS in Young Age (≤ 50) Women (CUSTOM): Multi-center Registry Study

NCT07311122 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.

NCT NCT07311122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07311122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Endocrine Therapy Plus Ovarian Function Suppression and Chemotherapy Based on 21-gene RS in Young Age (≤ 50) Women (CUSTOM): Multi-center Registry Study
Lead sponsor
Gangnam Severance Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
December 31, 2028
Enrollment
4,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer